|
1 Company |
|
0 Products |
|
0 Products |
|
0 Mechanisms of Action |
|
0 Trials |
|
4 News |
|
- | clindamycin phosphate / Generic mfg.
Trial completion, Enrollment change: Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge (clinicaltrials.gov) - Apr 16, 2015
P1, N=25, Completed, Sponsor: Sanaria Inc.
Active, not recruiting --> Completed | N=45 --> 25
- clindamycin phosphate / Generic mfg.
Enrollment closed: Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge (clinicaltrials.gov) - Apr 9, 2015
P1, N=45, Active, not recruiting, Sponsor: Sanaria Inc.
Active, not recruiting --> Completed | N=45 --> 25 Recruiting --> Active, not recruiting
- | clindamycin phosphate / Generic mfg.
New P1 trial: Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge (clinicaltrials.gov) - Sep 11, 2014
P1, N=45, Recruiting, Sponsor: Sanaria Inc.